Tag: computer aided drug discovery market forecast

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Computer-Aided Drug Discovery Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for AI-based clinical trial solution providers has experienced explosive growth over the recent period. From a valuation of $3.03 billion in 2025, it is projected to reach $3.72 billion by 2026, expanding at a compound annual growth rate (CAGR) of 22.9%. This historic rise has been driven by several factors, including the reliance on manual patient recruitment methods, the limited adoption of artificial intelligence within clinical trials, dependence on traditional data management systems, the high expense associated with conventional trial monitoring practices, and the fragmented nature of trial oversight.

The market for AI-based clinical trial solutions is projected to experience explosive growth over the coming years. Its value is anticipated to reach $8.53 billion by 2030, driven by a compound annual growth rate (CAGR) of 23.0%. This expansion during the forecast period is fueled by factors such as the improvement of AI algorithms for streamlining trial processes, the proliferation of cloud-based platforms for clinical research, increased funding for decentralized trial infrastructure, a heightened need for real-time data monitoring, and strategic alliances between pharmaceutical companies and AI solution developers. Key emerging trends include the application of AI to enhance patient recruitment, the growing incorporation of AI-driven data analytics within clinical trials, the spread of virtual and decentralized study models, the use of real-world evidence combined with predictive modeling, and a rising emphasis on automating regulatory compliance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp

Computer-Aided Drug Discovery Market Growth Drivers: What Factors Are Accelerating Expansion?

The growing integration of artificial intelligence is set to accelerate the advancement of the AI-powered clinical trial solution provider market. AI involves systems capable of replicating human cognitive functions, such as machine learning and deep learning, which introduce automation, efficiency, and data-driven analysis into complex operations. As clinical trial solution providers increasingly rely on AI, they facilitate streamlined patient selection, enhanced predictions for trial outcomes, continuous safety oversight in real time, and shorter study durations, thereby improving the overall clinical trial process. To illustrate, a March 2024 report from the United States Census Bureau, a federal statistical body, noted a swift rise in AI deployment, going from 3.7% of businesses in Fall 2023 to 5.4% by February 2024. Consequently, this expanding adoption of AI technology is fueling progress in the AI-based clinical trial solution provider market.

Computer-Aided Drug Discovery Market Segment Performance And Strategic Opportunities

The ai-based clinical trial solution providers market covered in this report is segmented –

1) By Clinical Trial Phase: Phase-I, Phase-II, Phase-III

2) By Therapeutic Application: Oncology, Cardiovascular Diseases, Neurological Diseases Or Conditions Metabolic Diseases, Infectious Diseases, Other Therapeutic Applications

3) By End-User: Pharmaceutical Companies, Academia

Subsegments:

1) By Phase-I: Safety And Dosage Studies, Early Pharmacokinetics Studies

2) By Phase-II: Efficacy Studies, Dose-Response Studies

3) By Phase-III: Confirmatory Studies, Comparative Effectiveness Research

Computer-Aided Drug Discovery Market Trends: What Is Shaping Future Industry Growth?

Major players in the AI-based clinical trial solution providers market are introducing cutting-edge technological advancements, such as the Saama AI-driven data platform, to speed up clinical development and solidify their market presence. This AI-driven data platform is a software tool that uses artificial intelligence and machine learning to automate and improve data management and analysis tasks. For example, in June 2023, Saama Technologies, Inc., a software firm based in the United States, launched an AI-powered data platform named Saama. By centralizing and standardizing data, this platform simplifies clinical trial processes, delivering real-time insights into trial operations, finances, and patient information. It employs AI and advanced analytics to automate tasks, boost productivity, and offer detailed understanding of patient behaviors. Through SaaS offerings like data hubs, operational insights, patient insights, S2S, and SDQ, Saama enables AI-based clinical trial solution providers to enhance efficiency, accuracy, and effectiveness. Moreover, it seeks to eliminate manual, resource-heavy tasks, making clinical trials more streamlined and impactful.

Computer-Aided Drug Discovery Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the ai-based clinical trial solution providers market are International Business Machines Corporation, IQVIA Holdings Inc., Saama Technologies Inc., AiCure LLC, Deep 6 AI Inc., DEEP LENS AI Inc., Unlearn.AI Inc., Intelligencia Inc., Median Technologies SAS, PathAI Inc., Koneksa Health Inc., GNS Healthcare Inc., CytoReason, Ardigen, BenevolentAI SA, Exscientia, Mendel Health Inc., Concentro Health AI, Antidote Technologies Inc., TriNetX Inc., Phesi

Access The Complete Computer-Aided Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Computer-Aided Drug Discovery Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the AI-based clinical trial solution providers market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai-based clinical trial solution providers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Computer-Aided Drug Discovery Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28919&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Computer-Aided Drug Discovery Market?

The computer-aided drug discovery market has seen rapid expansion in recent years. It is projected to grow from $7.56 billion in 2025 to $8.54 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. Historically, this expansion has been driven by factors such as the increasing intricacy of drug development processes, greater investment in pharmaceutical research and development, the broadening scope of computational biology capabilities, the increasing volume of accessible biological data, and the incorporation of in silico modeling techniques.

The computer-aided drug discovery market is anticipated to experience significant expansion in the near future. Its valuation is projected to reach $13.69 billion by 2030, progressing at a compound annual growth rate (CAGR) of 12.5%. The projected growth is driven by several factors, including greater investments in AI-enabled drug discovery, an increasing need for expedited drug development processes, the widening scope of personalized medicine research, the deeper integration of machine learning in pharmacology, and an expanded utilization of cloud computing for extensive simulations. Prominent developments expected throughout this period encompass a rise in the application of AI-driven virtual screening, increased adoption of molecular docking simulations, more extensive integration of genomic data into drug design, the growth of cloud-based drug discovery platforms, and a stronger emphasis on the accuracy of predictive modeling.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp

What Market Drivers Are Helping Shape The Computer-Aided Drug Discovery Market Expansion?

The increasing incidence of cancer is anticipated to fuel the expansion of the computer-aided drug discovery market. Cancer, characterized by the unregulated proliferation and division of abnormal cells, sees its rising prevalence attributed to factors like lifestyle shifts, urbanization, environmental contamination, tobacco and alcohol use, and issues with healthcare accessibility and public awareness. Computer-aided drug discovery offers a means to develop drugs specifically targeting cancer cells with unique genetic mutations, thereby enabling more personalized and effective cancer treatments. For instance, data from July 2024, released by the Australian Institute of Health and Welfare, an Australia-based government agency, revealed approximately 165,000 new cancer cases were diagnosed in 2023. This figure is projected to rise to about 204,000 cases annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Thus, the escalating prevalence of cancer cases is a key driver for the computer-aided drug discovery market.

Which Segment Divisions Form The Structure Of The Computer-Aided Drug Discovery Market?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

What Trends Are Affecting The Computer-Aided Drug Discovery Market Dynamics?

Major companies in the computer-aided drug discovery (CADD) market are creating innovative solutions, including artificial intelligence in drug discovery, to boost the accuracy, speed, and efficiency of identifying potential drug candidates, refining lead compounds, and facilitating personalized medicine development. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies like machine learning and deep learning, utilizing advanced algorithms to make the discovery and development of new drugs quicker, more efficient, and more exact. As an illustration, in December 2023, Merck KGaA, a Germany-based science and technology company, unveiled AIDDISONTM, the first software-as-a-service platform designed to integrate drug discovery and synthesis. By combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development through the virtual screening of compounds from over 60 billion chemical targets and the recommendation of optimal synthesis routes. The platform has been trained on two decades of pharmaceutical R&D data to identify drug-like candidates with desirable attributes such as non-toxicity and stability. Moreover, by incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM enhances drug manufacturing for improved efficiency and sustainability, with the objective of lowering the cost and time associated with drug discovery.

Which Companies Form The Competitive Landscape Of The Computer-Aided Drug Discovery Market?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Access The Complete Computer-Aided Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Region Leads The Computer-Aided Drug Discovery Market By Size?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Computer-Aided Drug Discovery Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=19379&type=smp

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Diagnostic Contract Manufacturing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-contract-manufacturing-global-market-report

Ai In Medical Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Computer-Aided Drug Discovery Market Progress Between 2026 And 2030?

The computer-aided drug discovery market has experienced rapid growth in recent years. It is projected to expand from $7.56 billion in 2025 to $8.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. The market’s historical development can be attributed to factors such as the increasing complexity of drug development processes, rising R&D expenditure in pharmaceuticals, the expansion of computational biology capabilities, the growing availability of biological data, and the adoption of in silico modeling techniques.

The computer-aided drug discovery market size is projected for substantial expansion in the coming years. It is expected to reach $13.69 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is fueled by increasing investments in AI-enabled drug discovery, a rising demand for expedited drug development cycles, the expansion of personalized medicine research, a growing integration of machine learning in pharmacology, and the increasing use of cloud computing for large-scale simulations. Prominent trends throughout the forecast period include the increasing use of AI-driven virtual screening, a rising adoption of molecular docking simulations, the growing integration of genomic data in drug design, the expansion of cloud-based drug discovery platforms, and an enhanced focus on predictive modeling accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Key Drivers Are Affecting The Computer-Aided Drug Discovery Market Development?

The increasing occurrence of cancer is anticipated to propel the expansion of the computer-aided drug discovery market. Cancer is defined as a collection of diseases characterized by the unregulated proliferation and division of abnormal cells in the body. The growing incidence of cancer cases is attributed to multiple factors, including changes in lifestyle and urbanization, environmental pollution, consumption of tobacco and alcohol, and variations in healthcare access and awareness. Computer-aided drug discovery offers a means to develop drugs specifically aimed at cancer cells exhibiting particular genetic mutations, thereby opening avenues for more customized and effective cancer therapies. For example, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that around 165,000 new cancer cases were diagnosed in 2023. Projections further suggest that approximately 204,000 cases will be diagnosed annually by 2033, culminating in an estimated total of 1.9 million cancer cases between 2024 and 2033. Hence, the escalating prevalence of cancer cases is a significant driver for the computer-aided drug discovery market.

How Is Segmentation Applied In The Computer-Aided Drug Discovery Market Segment Analysis?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

What Trends Are Transforming The Computer-Aided Drug Discovery Market?

Major companies operating in the computer-aided drug discovery (CADD) market are developing advanced solutions, including artificial intelligence in drug discovery, to improve the accuracy, speed, and efficiency of identifying potential drug candidates, optimizing lead compounds, and facilitating the development of personalized medicine. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies, such as machine learning and deep learning, utilizing sophisticated algorithms to make the discovery and development of new drugs faster, more efficient, and more precise. As an example, in December 2023, Merck KGaA, a Germany-based science and technology company, introduced AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. Combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development by virtually screening compounds from over 60 billion chemical targets and recommending optimal synthesis routes. The platform has been trained on two decades of pharmaceutical R&D data to identify drug-like candidates with properties like non-toxicity and stability. By incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug manufacturing for efficiency and sustainability, aiming to reduce the cost and time associated with drug discovery.

Who Are The Companies Participating In The Computer-Aided Drug Discovery Market Environment?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Get The Full Computer-Aided Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Region Represents The Largest Share Of The Computer-Aided Drug Discovery Market?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Computer-Aided Drug Discovery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Informatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Computer Aided Oral And Maxillofacial Surgery Market Report 2026

https://www.thebusinessresearchcompany.com/report/computer-aided-oral-and-maxillofacial-surgery-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Computer-Aided Drug Discovery Market Progress Between 2026 And 2030?

The computer-aided drug discovery market has experienced rapid growth in recent years. It is projected to expand from $7.56 billion in 2025 to $8.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. The market’s historical development can be attributed to factors such as the increasing complexity of drug development processes, rising R&D expenditure in pharmaceuticals, the expansion of computational biology capabilities, the growing availability of biological data, and the adoption of in silico modeling techniques.

The computer-aided drug discovery market size is projected for substantial expansion in the coming years. It is expected to reach $13.69 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is fueled by increasing investments in AI-enabled drug discovery, a rising demand for expedited drug development cycles, the expansion of personalized medicine research, a growing integration of machine learning in pharmacology, and the increasing use of cloud computing for large-scale simulations. Prominent trends throughout the forecast period include the increasing use of AI-driven virtual screening, a rising adoption of molecular docking simulations, the growing integration of genomic data in drug design, the expansion of cloud-based drug discovery platforms, and an enhanced focus on predictive modeling accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Key Drivers Are Affecting The Computer-Aided Drug Discovery Market Development?

The increasing occurrence of cancer is anticipated to propel the expansion of the computer-aided drug discovery market. Cancer is defined as a collection of diseases characterized by the unregulated proliferation and division of abnormal cells in the body. The growing incidence of cancer cases is attributed to multiple factors, including changes in lifestyle and urbanization, environmental pollution, consumption of tobacco and alcohol, and variations in healthcare access and awareness. Computer-aided drug discovery offers a means to develop drugs specifically aimed at cancer cells exhibiting particular genetic mutations, thereby opening avenues for more customized and effective cancer therapies. For example, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that around 165,000 new cancer cases were diagnosed in 2023. Projections further suggest that approximately 204,000 cases will be diagnosed annually by 2033, culminating in an estimated total of 1.9 million cancer cases between 2024 and 2033. Hence, the escalating prevalence of cancer cases is a significant driver for the computer-aided drug discovery market.

How Is Segmentation Applied In The Computer-Aided Drug Discovery Market Segment Analysis?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

What Trends Are Transforming The Computer-Aided Drug Discovery Market?

Major companies operating in the computer-aided drug discovery (CADD) market are developing advanced solutions, including artificial intelligence in drug discovery, to improve the accuracy, speed, and efficiency of identifying potential drug candidates, optimizing lead compounds, and facilitating the development of personalized medicine. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies, such as machine learning and deep learning, utilizing sophisticated algorithms to make the discovery and development of new drugs faster, more efficient, and more precise. As an example, in December 2023, Merck KGaA, a Germany-based science and technology company, introduced AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. Combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development by virtually screening compounds from over 60 billion chemical targets and recommending optimal synthesis routes. The platform has been trained on two decades of pharmaceutical R&D data to identify drug-like candidates with properties like non-toxicity and stability. By incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug manufacturing for efficiency and sustainability, aiming to reduce the cost and time associated with drug discovery.

Who Are The Companies Participating In The Computer-Aided Drug Discovery Market Environment?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Get The Full Computer-Aided Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Region Represents The Largest Share Of The Computer-Aided Drug Discovery Market?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Computer-Aided Drug Discovery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Informatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Computer Aided Oral And Maxillofacial Surgery Market Report 2026

https://www.thebusinessresearchcompany.com/report/computer-aided-oral-and-maxillofacial-surgery-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Computer-Aided Drug Discovery Market Progress Between 2026 And 2030?

The computer-aided drug discovery market has experienced rapid growth in recent years. It is projected to expand from $7.56 billion in 2025 to $8.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. The market’s historical development can be attributed to factors such as the increasing complexity of drug development processes, rising R&D expenditure in pharmaceuticals, the expansion of computational biology capabilities, the growing availability of biological data, and the adoption of in silico modeling techniques.

The computer-aided drug discovery market size is projected for substantial expansion in the coming years. It is expected to reach $13.69 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is fueled by increasing investments in AI-enabled drug discovery, a rising demand for expedited drug development cycles, the expansion of personalized medicine research, a growing integration of machine learning in pharmacology, and the increasing use of cloud computing for large-scale simulations. Prominent trends throughout the forecast period include the increasing use of AI-driven virtual screening, a rising adoption of molecular docking simulations, the growing integration of genomic data in drug design, the expansion of cloud-based drug discovery platforms, and an enhanced focus on predictive modeling accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Key Drivers Are Affecting The Computer-Aided Drug Discovery Market Development?

The increasing occurrence of cancer is anticipated to propel the expansion of the computer-aided drug discovery market. Cancer is defined as a collection of diseases characterized by the unregulated proliferation and division of abnormal cells in the body. The growing incidence of cancer cases is attributed to multiple factors, including changes in lifestyle and urbanization, environmental pollution, consumption of tobacco and alcohol, and variations in healthcare access and awareness. Computer-aided drug discovery offers a means to develop drugs specifically aimed at cancer cells exhibiting particular genetic mutations, thereby opening avenues for more customized and effective cancer therapies. For example, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that around 165,000 new cancer cases were diagnosed in 2023. Projections further suggest that approximately 204,000 cases will be diagnosed annually by 2033, culminating in an estimated total of 1.9 million cancer cases between 2024 and 2033. Hence, the escalating prevalence of cancer cases is a significant driver for the computer-aided drug discovery market.

How Is Segmentation Applied In The Computer-Aided Drug Discovery Market Segment Analysis?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

What Trends Are Transforming The Computer-Aided Drug Discovery Market?

Major companies operating in the computer-aided drug discovery (CADD) market are developing advanced solutions, including artificial intelligence in drug discovery, to improve the accuracy, speed, and efficiency of identifying potential drug candidates, optimizing lead compounds, and facilitating the development of personalized medicine. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies, such as machine learning and deep learning, utilizing sophisticated algorithms to make the discovery and development of new drugs faster, more efficient, and more precise. As an example, in December 2023, Merck KGaA, a Germany-based science and technology company, introduced AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. Combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development by virtually screening compounds from over 60 billion chemical targets and recommending optimal synthesis routes. The platform has been trained on two decades of pharmaceutical R&D data to identify drug-like candidates with properties like non-toxicity and stability. By incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug manufacturing for efficiency and sustainability, aiming to reduce the cost and time associated with drug discovery.

Who Are The Companies Participating In The Computer-Aided Drug Discovery Market Environment?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Get The Full Computer-Aided Drug Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Region Represents The Largest Share Of The Computer-Aided Drug Discovery Market?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Computer-Aided Drug Discovery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Informatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Computer Aided Oral And Maxillofacial Surgery Market Report 2026

https://www.thebusinessresearchcompany.com/report/computer-aided-oral-and-maxillofacial-surgery-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Computer-Aided Drug Discovery Market By The End Of 2030?

The computer-aided drug discovery market has seen rapid expansion in recent years. It is forecast to grow from $7.56 billion in 2025 to $8.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.9%. This historical growth can be attributed to factors such as the increasing complexity of drug development processes, a rise in R&D expenditure within pharmaceuticals, the expansion of computational biology capabilities, the growing availability of biological data, and the widespread adoption of in silico modeling techniques.

The computer-aided drug discovery market size is expected to experience rapid expansion in the coming years. It is projected to reach $13.69 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is attributable to increasing investments in AI-enabled drug discovery, a rising demand for quicker drug development cycles, the expansion of personalized medicine research, the growing integration of machine learning in pharmacology, and the increasing use of cloud computing for large-scale simulations. Major trends anticipated in this period include the rising use of AI-driven virtual screening, an increase in the adoption of molecular docking simulations, the growing incorporation of genomic data in drug design, the expansion of cloud-based drug discovery platforms, and an enhanced focus on the accuracy of predictive modeling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp

Which Market Drivers Are Supporting The Expansion Of The Computer-Aided Drug Discovery Market?

The increasing incidence of cancer cases is projected to stimulate the expansion of the computer-aided drug discovery market in the future. Cancer constitutes a range of illnesses marked by the uncontrolled multiplication and division of abnormal cells within the body. The upward trend in cancer diagnoses stems from various influences, such as changes in lifestyle and urban environments, environmental pollution, intake of tobacco and alcohol, and differences in healthcare availability and public understanding. Computer-aided drug discovery provides a means to formulate drugs designed to target cancer cells possessing specific genetic mutations, thereby enabling the development of more personalized and effective cancer treatments. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, about 165,000 new cancer cases were identified in 2023, with projections indicating that approximately 204,000 cases will be diagnosed annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Hence, the growing prevalence of cancer cases is a key driver for the computer-aided drug discovery market.

Which Segment Classifications Shape The Computer-Aided Drug Discovery Market?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

Which Trends Are Shaping The Future Of The Computer-Aided Drug Discovery Market?

Leading companies operating in the computer-aided drug discovery (CADD) market are developing innovative solutions, including Artificial intelligence (AI) in drug discovery, to enhance the accuracy, speed, and efficiency of identifying potential drug candidates, optimizing lead compounds, and facilitating the development of personalized medicine. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies, such as machine learning and deep learning, leveraging advanced algorithms to make discovering and developing new drugs faster, more efficient, and more precise. For instance, in December 2023, Merck KGaA, a Germany-based science and technology company, launched AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. Combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development by virtually screening compounds from over 60 billion chemical targets and recommending optimal synthesis routes. The platform is trained on two decades of pharmaceutical R&D data to identify drug-like candidates with properties such as non-toxicity and stability. By incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug manufacturing for efficiency and sustainability, aiming to reduce the cost and time of drug discovery.

Which Companies Are Expanding Their Footprint In The Computer-Aided Drug Discovery Market?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Read the full computer-aided drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

How Is The Computer-Aided Drug Discovery Market Distributed Across Key Geographic Regions?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Computer-Aided Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19379&type=smp

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Diagnostic Contract Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/diagnostic-contract-manufacturing-global-market-report

Ai In Medical Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model